BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 24962282)

  • 1. Small molecules, peptides and natural products: getting a grip on 14-3-3 protein-protein modulation.
    Bartel M; Schäfer A; Stevers LM; Ottmann C
    Future Med Chem; 2014 May; 6(8):903-21. PubMed ID: 24962282
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Small-Molecule Stabilization of the 14-3-3/Gab2 Protein-Protein Interaction (PPI) Interface.
    Bier D; Bartel M; Sies K; Halbach S; Higuchi Y; Haranosono Y; Brummer T; Kato N; Ottmann C
    ChemMedChem; 2016 Apr; 11(8):911-8. PubMed ID: 26644359
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The phytotoxin fusicoccin differently regulates 14-3-3 proteins association to mode III targets.
    Paiardini A; Aducci P; Cervoni L; Cutruzzolà F; Di Lucente C; Janson G; Pascarella S; Rinaldo S; Visconti S; Camoni L
    IUBMB Life; 2014 Jan; 66(1):52-62. PubMed ID: 24408864
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Strategies to search and design stabilizers of protein-protein interactions: a feasibility study.
    Block P; Weskamp N; Wolf A; Klebe G
    Proteins; 2007 Jul; 68(1):170-86. PubMed ID: 17393392
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Structural basis of 14-3-3 protein functions.
    Obsil T; Obsilova V
    Semin Cell Dev Biol; 2011 Sep; 22(7):663-72. PubMed ID: 21920446
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Small-molecule modulators of 14-3-3 protein-protein interactions.
    Ottmann C
    Bioorg Med Chem; 2013 Jul; 21(14):4058-62. PubMed ID: 23266179
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An optimised small-molecule stabiliser of the 14-3-3-PMA2 protein-protein interaction.
    Richter A; Rose R; Hedberg C; Waldmann H; Ottmann C
    Chemistry; 2012 May; 18(21):6520-7. PubMed ID: 22467351
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Stabilization and inhibition of protein-protein interactions: the 14-3-3 case study.
    Milroy LG; Brunsveld L; Ottmann C
    ACS Chem Biol; 2013 Jan; 8(1):27-35. PubMed ID: 23210482
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Targeting protein-protein interactions for therapeutic intervention: a challenge for the future.
    Zinzalla G; Thurston DE
    Future Med Chem; 2009 Apr; 1(1):65-93. PubMed ID: 21426071
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The phytotoxin fusicoccin, a selective stabilizer of 14-3-3 interactions?
    Camoni L; Visconti S; Aducci P
    IUBMB Life; 2013 Jun; 65(6):513-7. PubMed ID: 23568668
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Protein-protein interactions as drug targets.
    Skwarczynska M; Ottmann C
    Future Med Chem; 2015; 7(16):2195-219. PubMed ID: 26510391
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fast and reliable prediction of domain-peptide binding affinity using coarse-grained structure models.
    Tian F; Tan R; Guo T; Zhou P; Yang L
    Biosystems; 2013 Jul; 113(1):40-9. PubMed ID: 23665477
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Small-molecule inhibitors of protein-protein interactions: progressing toward the reality.
    Arkin MR; Tang Y; Wells JA
    Chem Biol; 2014 Sep; 21(9):1102-14. PubMed ID: 25237857
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rational Design, Binding Studies, and Crystal-Structure Evaluation of the First Ligand Targeting the Dimerization Interface of the 14-3-3ζ Adapter Protein.
    Ehlers M; Grad JN; Mittal S; Bier D; Mertel M; Ohl L; Bartel M; Briels J; Heimann M; Ottmann C; Sanchez-Garcia E; Hoffmann D; Schmuck C
    Chembiochem; 2018 Mar; 19(6):591-595. PubMed ID: 29282826
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 14-3-3 proteins: regulators of numerous eukaryotic proteins.
    van Heusden GP
    IUBMB Life; 2005 Sep; 57(9):623-9. PubMed ID: 16203681
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bioactivity-guided navigation of chemical space.
    Bon RS; Waldmann H
    Acc Chem Res; 2010 Aug; 43(8):1103-14. PubMed ID: 20481515
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Progress in discovery of small-molecule modulators of protein-protein interactions via fragment screening.
    Magee TV
    Bioorg Med Chem Lett; 2015 Jun; 25(12):2461-8. PubMed ID: 25971770
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A semisynthetic fusicoccane stabilizes a protein-protein interaction and enhances the expression of K+ channels at the cell surface.
    Anders C; Higuchi Y; Koschinsky K; Bartel M; Schumacher B; Thiel P; Nitta H; Preisig-Müller R; Schlichthörl G; Renigunta V; Ohkanda J; Daut J; Kato N; Ottmann C
    Chem Biol; 2013 Apr; 20(4):583-93. PubMed ID: 23601647
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Selectivity via Cooperativity: Preferential Stabilization of the p65/14-3-3 Interaction with Semisynthetic Natural Products.
    Wolter M; de Vink P; Neves JF; Srdanović S; Higuchi Y; Kato N; Wilson A; Landrieu I; Brunsveld L; Ottmann C
    J Am Chem Soc; 2020 Jul; 142(27):11772-11783. PubMed ID: 32501683
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Design of Drug-Like Protein-Protein Interaction Stabilizers Guided By Chelation-Controlled Bioactive Conformation Stabilization.
    Bosica F; Andrei SA; Neves JF; Brandt P; Gunnarsson A; Landrieu I; Ottmann C; O'Mahony G
    Chemistry; 2020 Jun; 26(31):7131-7139. PubMed ID: 32255539
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.